ePrivacy and GPDR Cookie Consent by TermsFeed Generator
Home / Medicinal products database / Detail of medicinal product

GAVISCON

250MG/133,5MG/80MG TBL MND 6

Main Texts Price and reimbursement Availability Foreign language batch Contacts
SPC - Summary of product characteristics gaviscon-spc.pdf
NR - Registration decision
PIL - Package leaflet gaviscon-pil.pdf
PAR - Public assessment report  
Text on the wrap gaviscon-obal.pdf
Braills Approved – name of the medicinal product in Braille on the packaging was confirmed.
SPCs and PILs of centralised medicinal products (registration number beginning EU) are included as a link to website of the European Medicines Agency (EMEA) Information is available on this website in section Product Information. Please note that the texts refer to all strenghts and pharmaceutical forms of the given medicinal product. SUKL is not responsible for update SPCs and PILs on EMEA web site.

EAN – more specific information about EAN code is available in the Overview

I - neregistrovaný léčivý přípravek jehož distribuce, výdej a použití je umožněno na základě opatření Ministerstva zdravotnictví ČR podle § 8 odst. 6 zákona o léčivech.

Back to list

 

2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@sukl_cz.

Web portal supplier - QCM, s.r.o.